Our finding that late age at menarche is associated with a reduced risk of both ER+PR+ and ER- PR- breast cancer is consistent with two [19,20] of four previous case–control studies conducted among women under 45 years [19,20] or premenopausal women [12,22]. This evidence concerns the gene ESR1 and breast carcinoma.